Probing the role of PPARγ in the regulation of late-onset Alzheimer's disease-associated genes.
Peroxisome proliferator-activated receptor-γ (PPARγ), is a transcription factor that governs pathways, such as lipid metabolism and immune response, that have been implicated in the etiology of LOAD. Previously, we established HepG2-derived cell-lines with stable knockdown of PPARγ gene, and showed...
Main Authors: | Julio Barrera, Shobana Subramanian, Ornit Chiba-Falek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5933777?pdf=render |
Similar Items
-
<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
by: Anna Yang, et al.
Published: (2021-01-01) -
Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
by: Misha Angrist, et al.
Published: (2020-10-01) -
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
by: Julia Gamache, et al.
Published: (2020-08-01) -
Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer’s disease brains
by: Julio Barrera, et al.
Published: (2021-08-01) -
Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
by: Manoj Govindarajulu, et al.
Published: (2018-01-01)